Heart surgery bleeding study seeks best drug dose
NCT ID NCT07164300
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study looks at different doses of tranexamic acid, a medicine used to prevent bleeding during heart surgery. The goal is to find out which dose works best to stop bleeding and reduce the need for blood transfusions. About 150 adults having planned heart surgery with a heart-lung machine will take part. Researchers will take blood samples to measure how long the medicine stays active.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVERSE DRUG EVENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Ioannina
RECRUITINGIoannina, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.